SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-028594
Filing Date
2021-05-18
Accepted
2021-05-18 12:08:41
Documents
9
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lhdx-8k_20210513.htm 8-K 37303
2 EX-99.1 lhdx-ex991_6.htm EX-99.1 356575
3 GRAPHIC goxghrlgbkyp000003.jpg GRAPHIC 996
4 GRAPHIC goxghrlgbkyp000005.jpg GRAPHIC 996
5 GRAPHIC goxghrlgbkyp000002.jpg GRAPHIC 996
6 GRAPHIC goxghrlgbkyp000006.jpg GRAPHIC 996
7 GRAPHIC goxghrlgbkyp000001.jpg GRAPHIC 2074
8 GRAPHIC goxghrlgbkyp000004.jpg GRAPHIC 996
9 GRAPHIC goxghrlgbkyp000007.jpg GRAPHIC 996
  Complete submission text file 0001564590-21-028594.txt   407249
Mailing Address 1412 62ND STREET EMERYVILLE CA 94608
Business Address 1412 62ND STREET EMERYVILLE CA 94608 (814) 574-1546
Lucira Health, Inc. (Filer) CIK: 0001652724 (see all company filings)

IRS No.: 272491037 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39976 | Film No.: 21935035
SIC: 2835 In Vitro & In Vivo Diagnostic Substances